We read with great interest the recent series of papers published in European Urology related to current uro-oncology practice during the COVID-19 pandemic. The papers report that doctors are doing their best for the patients, with minimal delays in the diagnosis and treatment of urogenital neoplasms [1,2]. This involves what we can call social interaction, visibility, and social distance. These three items, as discussed below, concern clinicians, uropathologists, and patients.